Answers are grounded in this paper and cite their sources.
Aim Metformin has been reported to improve age-related diseases, including dementia. Prior studies have suggested that metformin use is associated with a decreased risk of delirium. This study aimed to analyze the medical records of surgical patients with comorbid type 2 diabetes to evaluate the relationship between metformin and both postoperative delirium. Method A retrospective cohort study of patients diagnosed with type 2 diabetes who underwent surgery for malignancy in the Departments of Gastrointestinal Surgery and Thoracic Surgery was conducted. A total of 1,159 patients were analyzed to examine metformin use and the incidence of delirium. Results Among the 1,159 patients, 1,026 were classified as the non-metformin-treated diabetes group and 133 as the metformin-treated diabetes group. The incidence of delirium was 17.0% in the non-metformin-treated group and 15.0% in the metformin-treated group. Metformin use was not associated with a reduced risk of delirium after adjustment for confounding factors (Relative risk: 0.94, 95% confidence interval [CI], 0.60~1.45, p = 0.766). The propensity score weighting analyses showed no significant association between metformin use and the incidence of postoperative delirium (Relative risk: 1.51, 95% CI, 0.62~3.69, p = 0.370). Conclusion In this study, metformin use was not significantly associated with postoperative delirium.
No takes yet. Share an insight, caveat, or question.
Kajitani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: